SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-221790
Filing Date
2024-09-19
Accepted
2024-09-19 08:30:30
Documents
15
Period of Report
2024-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d836959d8k.htm   iXBRL 8-K 32114
2 EX-4.1 d836959dex41.htm EX-4.1 96680
3 EX-10.1 d836959dex101.htm EX-10.1 50043
  Complete submission text file 0001193125-24-221790.txt   343196

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240917.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240917_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240917_pre.xml EX-101.PRE 10806
18 EXTRACTED XBRL INSTANCE DOCUMENT d836959d8k_htm.xml XML 3533
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 241309163
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)